[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.98.119. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 182
Citations 0
Letters
August 22/29, 2012

Cardiac Device Infective Endocarditis and Patient Survival

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Maimonides Medical Center, Brooklyn, New York (abhisheksharma4mamc@gmail.com).

JAMA. 2012;308(8):761. doi:10.1001/jama.2012.9240

To the Editor: The study by Dr Athan and colleagues1 about the clinical characteristics and outcomes of CDIE evaluated the association between device removal and clinical outcomes. We would like to raise a few points about the analysis that may be pertinent.

First, cardiac resynchronization therapy is another predictor of long-term mortality after infection of cardiac implantable devices.2 It would be interesting to know if the authors investigated differences in the rate of infection and mortality in patients with dual-chamber pacemakers vs ventricular pacemakers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×